INTERNATIONAL PATENT: NEUROGASTRX, INC. FILES APPLICATION FOR "METOPIMAZINE AND ITS SALTS AS ADJUNCT THERAPY WITH GLP-1 AGONISTS"

GENEVA, April 20 -- NEUROGASTRX, INC. (600 Unicorn Park DriveWoburn, Massachusetts 01801) filed a patent application (PCT/US2025/050044) for "METOPIMAZINE AND ITS SALTS AS ADJUNCT THERAPY WITH GLP-1 AGONISTS" on Oct 08, 2025. With publication no. WO/2026/080594, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): O'MARA, James (c/o Neurogastrx, Inc.600 Unicorn Park DriveWoburn, Massachusetts 01801), DE COLLE, Cyril (c/o Neurogastrx, Inc.600 Unicorn Park DriveWoburn, Massachusetts 01801), ROGERS, Paul (c/o Neurogastrx, Inc.600...